Functional comparison of endothelin receptors in human and rat pulmonary artery smooth muscle

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 272, Issue 2 16-2, 1997, Pages

  Bialecki, Russell A ^a,b   Fisher, Carol S ^a   Murdoch, Wallace W ^a   Barthlow, Herbert G ^a   Bertelsen, Darci L ^a  

^a Zeneca Pharmaceutical   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

BMS 182874; BQ 123; BQ 788; endothelin A receptor; endothelin B receptor

Indexed keywords

ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY MUSCLE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PULMONARY ARTERY; RAT; RECEPTOR BLOCKING; SPECIES DIFFERENCE;

EID: 0030910692     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1997.272.2.l211     Document Type: Article

References (32)

1. Bialecki, R. A., and T. N. Tulenko. Excess membrane cholesterol alters calcium channels in arterial smooth muscle. Am. J. Physiol. 257 (Cell Physiol. 26): C306-C314, 1989.
2. A receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation. J. Cardiovasc. Pharmacol. 22: 39-43, 1993.
3. Cody, R. J., G. J. Haas, P. F. Binkley, Q. Capers, and R. Kelley. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85: 504-509, 1992.
4. DiCarlo, V. S., S. J. Chen, Q. C. Meng, J. Durand, M. Yano, Y. F. Chen, and S. Oparil. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L690-L697, 1995.
5. Fukuroda, T., M. Kobayashi, S. Ozaki, M. Yano, T. Miyauchi, M. Onizuka, Y. Sugishita, K. Goto, and M. Nishikibe. Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J. Appl Physiol. 76: 1976-1982, 1994.
6. Fukuroda, T., M. Nishikibe, Y. Ohta, M. Ihara, M. Yano, K. Ishikawa, T. Fukami, and F. Ikemoto. Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ-153. Life Sci. 50: PL-107-PL-112, 1992.
7. Giaid, A., M. Yanagisawa, D. Langloben, K. P. Michel, R. Levy, H. Shennib, S. Kimura, T. Masaki, W. P. Duguid, and D. J. Stewart. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328: 1732-1739, 1993.
8. Hay, D. W. P., M. A. Luttmann, W. C. Hubbard, and B. J. Undem. Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. Br. J. Pharmacol. 110: 1175-1183, 1993.
9. Ihara, M., K. Ishikawa, T. Fukuroda, T. Saeki, K. Funabashi, T. Fukami, H. Suda, and M. Yano. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETa receptor. J. Cardiovasc. Pharmacol. 20, Suppl. 12: S11-S14, 1992.
10. Ishikawa, K., M. Ihara, K. Noguchi, T. Mase, N. Mine, T. Saeki, T. Fukuroda, T. Fukami, S. Ozaki, T. Nagase, M. Nishikibe, and M. Yano. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA 91: 4892-4896, 1994.
11. Johnson, A. R., J. Ashton, W. Schulz, and E. G. Erdos. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am. Rev. Respir. Dis. 132: 564-568, 1985.
12. Kloog, Y., I. Ambar, M. Sokolovsky, E. Kochva, Z. Wollberg, and A. Bdolah. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science Wash. DC 242: 268-270, 1988.
13. Lang, D., and M. J. Lewis. Endothelium-derived relaxing factor inhibits the endothelin-1 induced increase in protein kinase C activity in rat aorta. Br. J. Pharmacol. 104: 139-144, 1991.
14. MacLean, M. R., K. M. McCulloch, and M. Baird. Effects of pulmonary hypertension on vasoconstrictor responses to endothelin-1 and sarafotoxin S6C and on inherent tone in rat pulmonary arteries. J. Cardiovasc. Pharmacol. 26: 822-830, 1995.
15. Martin, E. R., B. Brenner, and B. J. Ballerinan. Heterogeneity of cell surface endothelin receptors. J. Biol. Chem. 265: 14044-14049, 1990.
16. Masuda, Y., H. Miyazaki, M. Kondoh, H. Watanabe, M. Yanagisawa, T. Masaki, and K. Murakami. Two different forms of endothelin receptors in rat lung. FEBS Lett. 257: 208-210, 1989.
17. Miyauchi, T., R. Yorikane, S. Sakai, T. Sakurai, M. Okada, M. Nishikibe, M. Yano, I. Yamaguchi, Y. Sugishita, and K. Goto. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ. Res. 73: 887-897, 1993.
18. Moreland, S., D. M. McMullen, C. L. Delaney, V. G. Lee, and J. T. Hunt. Venous smooth muscle contains vasoconstrictor ETb-like receptors. Biochem. Biophys. Res. Commun. 184: 100-106, 1992.
19. Nishikibe, M., S. Tsuchida, M. Okada, T. Fukuroda, K. Shimamoto, M. Yano, K. Ishikawa, and F. Ikemoto. Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci. 52: 717-724, 1993.
20. Rapoport, R. M. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidyl inositol hydrolysis in rat aorta. Circ. Res. 58: 407-410, 1986.
21. Rosenberg, A. A., J. Kennaugh, S. L. Koppenhafer, M. Loomis, B. A. Chatfield, and S. H. Abman. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J. Pediatr. 123: 109-114, 1993.
22. Sakurai, T., M. Yanagisawa, and T. Masaki. Molecular characteristics of endothelin receptors. Trends Pharmacol. Sci. 13: 103-108, 1992.
23. A antagonist 5-(dimethyl-amino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide. J. Med. Chem. 37: 329-331, 1994.
24. Sudjarwo, S. A., M. Hori, M. Takai, Y. Urade, T. Okada, and H. Karaki. A novel subtype of endothelin B receptor mediating contraction in swine pulmonary vein. Life Sci. 53: 431-437, 1993.
25. Takimoto, M., T. Inui, T. Okada, and Y. Urade. Contraction of smooth muscle by activation of endothelin receptors on autonomic neurons. FEBS Lett. 324: 277-282, 1993.
26. Van Rossum, J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn. 143: 299-330, 1963.
27. Vijayaraghavan, J., A. G. Scicli, O.A. Carretero, C. Slaughter, C. Moomaw, and L. B. Hersh. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J. Biol. Chem. 265: 14150-14155, 1990.
28. Warner, T. D., G. H. Allcock, R. Corder, and J. R. Vane. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br. J. Pharmacol. 110: 777-782, 1993.
29. Warner, T. D., G. H. Allcock, E. J. Mickley, R. Corder, and J. R. Vane. Comparative studies with the endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors. J. Cardiovasc. Pharmacol. 22, Suppl. 8: S117-S120, 1993.
30. Warner, T. D., G. de Nucci, and J. R. Vane. Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur. J. Pharmacol. 159: 325-326, 1989.
31. Watanabe, T. X., Y. Itahara, K. Nakajima, S. Kumagaye, T. Kimura, and S. Sakakibara. The biological activity of endothelin-1 analogues in three different assay systems. J. Cardiovasc. Pharmacol. 17, Suppl. 7: S5-S9, 1991.
32. Yanagisawa, M., and T. Masaki. Molecular biology and biochemistry of the endothelins. Trends Pharmacol. Sci. 10: 374-378, 1989.